TXG compared with ARCT: revenue, margins and what each company keeps, and the suppliers and customers both name

TXG10x Genomics, Inc.

Mkt capRevenueRevenue

ARCTArcturus Therapeutics Holdings Inc.

Mkt capRevenueRevenue

Compare

TXG10x Genomics, Inc.

ARCTArcturus Therapeutics Holdings Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 499dMethod ›

Moved together

TXGwithARCT

×0.47co-movement · ARCT on TXG · 499d

r 0.39scale to r 0.75

No shared co-movers.

TXG, solidARCT, hatched× = co-movement · βr = correlationBar = r to r 0.75Source: daily closes

TXG10x Genomics, Inc.

58.11▼−13.94%· post 54.48

Mkt cap$8.8BRevenue$151MQ2 FY26Revenue$643MFY25

ARCTArcturus Therapeutics Holdings Inc.

9.37▼−13.76%· post 9.37

ClosedNov 5 '26

Mkt cap$309.0MRevenue$18MQ3 FY26Revenue$82MFY25

Compare

ClosedNov 5 '26

TXG10x Genomics, Inc.

ARCTArcturus Therapeutics Holdings Inc.

58.11▼−13.94%post 54.48

Price

9.37▼−13.76%post 9.37

$8.8B

Mkt cap

$309.0M

Q2 FY26$151M

Revenue

$18MQ3 FY26

FY25$643M

Revenue

$82MFY25

TXG58.11▼−13.94%vsARCT9.37▼−13.76%ClosedNov 5 '26